Lindbrook Capital »

Larimar Therapeutics shares owned by Lindbrook Capital

Quarter-by-quarter ownership of Larimar Therapeutics (LRMR) shares owned by Lindbrook Capital from 13F filings

Historical chart of Lindbrook Capital investment in Larimar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Larimar Therapeutics held by Lindbrook Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Larimar Therapeutics by Lindbrook Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $393 60 6.55
2024-06-30 $906 125 7.25

More positions owned by Lindbrook Capital

Vanguard Total Stk Mkt Etf (VTI)
Vanguard Total Intl Stock Idex Etf Etf (VXUS)
Apple Stock (AAPL)
Golub Cap Bdc Cef (GBDC)
Spdr S&p 500 Etf Trust Etf (SPY)
Ishares Russell 1000 Growth Etf Etf (IWF)
Nvidia Corporation Stock (NVDA)
Microsoft Stock (MSFT)
Rpar Risk Parity Etf Etf (RPAR)
Ishares Russell 1000 Value Etf Etf (IWD)
Amazon.com Stock (AMZN)
Powershares Qqq Tr Etf (QQQ)
Vertex Pharmaceuticals In Stock (VRTX)
Broadcom Stock (AVGO)
Vanguard Growth Etf Etf (VUG)

View all positions for Lindbrook Capital

Top funds holding Larimar Therapeutics

Deerfield Management Company
RA Capital Management
Henderson Group
Goldman Sachs Group
Blue Owl Capital Holdings
BlackRock
BlackRock
Vanguard Group
Verition Fund Management
Driehaus Capital Management
Woodline Partners
State Street Corporation
Geode Capital Management
Altium Capital Management
Fred Alger Management

View all funds holding Larimar Therapeutics